OPEN Foundation

Conducting PTSD clinical trials on a Schedule I drug: MDMA

Share This Post

Share on facebook
Share on linkedin
Share on twitter
Share on email

Knopf, A. (2016). Conducting PTSD clinical trials on a Schedule I drug: MDMA. Alcoholism & Drug Abuse Weekly, 28(47), 7-8. 
Link to full text

OPEN Foundation

Join ICPR 2022 Online!

ICPR features world-leading experts from many academic disciplines, including psychiatry, psychology, neuroscience, anthropology, ethnobotany, and philosophy who come together to give a scientific conference for academics, therapists, researchers, clinicians, policymakers, and members of the public. Get your ICPR 2022 livestream ticket today and use the code OPENLIVE30 at checkout for a €30 discount.

Learn More

INTERESTED IN PSYCHEDELIC RESEARCH AND THERAPIES?

Subscribe to our new OPEN-Minded newsletter to stay in the loop, hear about our events, and become a part of a community dedicated to advancing psychedelics.

By clicking subscribe, I confirm to receive emails from the OPEN Foundation and agree with its privacy policy.

16 April - Psilocybin Therapy for Bipolar Disorder Followed by a Live Q&A

X